Table 2.
Efficacy of treatment in the XELIRI and FOLFIRI arms (response rate, R0 resection* rate), data are shown as n (%)
| XELIRI | FOLFIRI | ||
|---|---|---|---|
| n = 41 | n = 46 | p | |
| Complete response | 5 (12%) | 1 (2%) | 0.10 |
| Partial response | 15 (37%) | 21 (46%) | 0.32 |
| Objective response | 20 (49%) | 22 (48%) | 0.76 |
| Stagnation | 12 (29%) | 10 (22%) | 0.67 |
| Progressive disease | 7 (17%) | 11 (24%) | 0.35 |
| R0 resection* | 10 (24%) | 11 (24%) | 0.83 |
| Complete response + R0 resection | 15 (37%) | 12 (26%) | 0.56 |
R0 resection* – > 10 mm tumour-free resection margin on histology